Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC) (CheckMate 017)
Clinical trial NCT01642004 · COMPLETED
Trial details
- NCT number
- NCT01642004
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-16
- Primary completion
- 2014-11-17
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.